Gene mutation found to drive prostate cancer subtype

A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists.

Defense Department award funds prostate cancer study

Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct a study of the molecular machinery driving the most aggressive prostate cancer.

'Radical collaboration' through machine learning

Trevor Pinch, the Goldwin Smith Professor of Science and Technology Studies, spent the fall 2016 semester on sabbatical at Cornell Tech in New York City, where he began collaborating with Serge Belongie, professor of computer science at Cornell Tech.

Study debunks old concept of how anesthesia works

Anesthesia induces unconsciousness by changing the function of proteins on the surface of a thin membrane that forms a barrier around all cells, according to Weill Cornell Medicine scientists.

Cell death in gut implicated in bowel disease

The natural life cycle of cells that line the intestine is critical to preserving stable conditions in the gut, according to new research led by a Weill Cornell Medicine investigator.

Discovery of genetic mutation may boost cancer therapies

A newly discovered type of genetic mutation in cancer cells may provide clues about the disease's origins and offer new therapeutic targets, according to research from Weill Cornell Medicine and the New York Genome Center.

Hospitable language inspires trust in Airbnb customers

Cornell researchers will present a paper on how Airbnb profiles are perceived in the context of a sharing economy that goes beyond their "gut feelings" if someone is trustworthy or not.

Cornell Tech app tracks bikers, reduces urban congestion

As part of Cornell Tech's Product Studio course, four Class of 2017 students developed technology to predict and avoid traffic jams via an app.

Weill Cornell to help plan international hospital in China

Weill Cornell Medicine has entered into an agreement with Tahoe Investment Group to assist in the development of an international hospital in Shanghai, China.